Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

434 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

A Long Term Safety Study With Atrasentan

NCT00127478

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations
  • Prostate Oncology Specialists Marina del Rey, California, United States
  • Western Clinical Research, Inc. Torrance, California, United States
  • South Florida Medical Research Aventura, Florida, United States
  • Beth Isreal Medical Center, Phillips Ambulatory Care Ceneter New York, United States
View all 15 locations
View Trial Details
Completed

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

NCT00191503

Conditions
Adenocarcinoma, Carcinoma, Neoplasms, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Calgary, Alberta, Canada
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Edmonton, Alberta, Canada
View Trial Details
Completed

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

NCT00042679

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +15 more
Locations
  • Bakersfield, California, United States
  • Berkeley, California, United States
  • Torrance, California, United States
  • Miami Beach, Florida, United States
View Trial Details
Completed

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

NCT00054873

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • ACRC/Arizona Clinical Research Center Tucson, Arizona, United States
  • Glendale Memorial Hospital Glendale, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

NCT05476796

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +12 more
Locations
  • Clinique de l'Europe Amiens, France
  • Hopital Privé Arras Les Bonnettes Arras, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de Beauvais Beauvais, France
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

NCT03653507

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • University of Kansas Cancer Center and Medical Pavilion Fairway, Kansas, United States
  • Ochsner Clinic CCOP New Orleans, Louisiana, United States
  • New Mexico Oncology Hematology Albuquerque, New Mexico, United States
View all 165 locations
View Trial Details
Active, Not Recruiting

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

NCT02864992

Conditions
Adenocarcinoma, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Bronchial Neoplasms, +13 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • St. Joseph Hospital Orange, California, United States
  • Torrance Health Association Redondo Beach, California, United States
View all 176 locations
View Trial Details

Related conditions